ArticleFrontiers in allergy2026
Contact sensitization to hair care allergens in scalp seborrheic dermatitis: associations with disease severity and microbiota profiles.
Article in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scalp seborrheic dermatitis (SSD) is a chronic inflammatory skin disorder characterized by impaired barrier function and intolerance to topical products. However, the relationship between contact sensitization and scalp microbiota in SSD remains unclear. Methods: A total of 63 participants underwent patch testing with 62 allergens and were grouped according to the presence or absence of scalp involvement. Clinical assessments included symptom severity, transepidermal water loss, and stratum corneum hydration. Bacterial 16S rRNA V3-V4 sequencing and fungal ITS1 sequencing were performed in a subset of 36 patients with SSD to evaluate associations between allergen sensitization and scalp microbiota. Results: The most frequent sensitizers in patients with SSD were cobalt chloride, cetrimonium bromide, p-methylaminophenol, nickel sulfate, decyl glucoside, and minoxidil, although overall sensitization rates did not differ significantly between SSD and control groups. Specific allergens were associated with age, sex, disease duration, and disease severity. Increased transepidermal water loss was correlated with fragrance and preservative allergens. Minoxidil sensitization was negatively associated with Conclusion: Patients with SSD showed distinct sensitization patterns associated with clinical characteristics, barrier dysfunction, and scalp microbiota alterations. These findings suggest that patch test reactivity in SSD should be interpreted in the broader context of allergen exposure, skin barrier status, and microbial imbalance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.